Production (Stage)
E
Lipella Pharmaceuticals Inc. LIPO
$2.99 -$0.10-3.24% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments 93.37% 61.40% 14.09% -43.64% -36.08%
Total Receivables 1.06% 172.35% -11.90% -48.77% 113.31%
Inventory -- -- -- -- --
Prepaid Expenses 47.45% -49.99% -19.07% 2.64% 710.16%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 84.29% 25.83% -0.04% -30.90% -12.19%

Total Current Assets 84.29% 25.83% -0.04% -30.90% -12.19%
Net Property, Plant & Equipment -42.23% -29.34% -22.46% -18.08% -14.74%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets 81.61% 23.79% -1.10% -30.38% -12.30%

Total Accounts Payable 1.00% -15.52% 157.57% -39.28% 112.90%
Total Accrued Expenses 13.21% 86.42% -17.95% 25.26% 5.19%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -49.58% -32.77% -24.44% 2.18% 2.80%
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 2.97% 7.59% 45.99% -12.97% 43.20%

Total Current Liabilities 2.97% 7.59% 45.99% -12.97% 43.20%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- -49.37%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 2.97% 7.59% 45.99% -16.60% 33.09%

Common Stock & APIC 20.08% 12.39% 8.47% 0.57% 4.52%
Retained Earnings -8.52% -10.37% -11.60% -8.15% -11.55%
Treasury Stock & Other -- -- -- -- --
Total Common Equity 112.52% 31.56% -14.37% -33.48% -18.54%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 112.52% 31.56% -14.37% -33.48% -18.54%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 112.51% 31.57% -14.37% -33.48% -18.54%